1. Home
  2. PGY vs SPTX Comparison

PGY vs SPTX Comparison

Compare PGY & SPTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pagaya Technologies Ltd.

PGY

Pagaya Technologies Ltd.

N/A

Current Price

$13.52

Market Cap

1.1B

Sector

Finance

ML Signal

N/A

Logo Seaport Therapeutics Inc. Common Stock

SPTX

Seaport Therapeutics Inc. Common Stock

N/A

Current Price

$18.05

Market Cap

1.1B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PGY
SPTX
Founded
2016
2024
Country
United States
United States
Employees
503
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.1B
IPO Year
2021
2026

Fundamental Metrics

Financial Performance
Metric
PGY
SPTX
Price
$13.52
$18.05
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
11
9
Target Price
$29.45
★ $37.13
AVG Volume (30 Days)
★ 1.8M
283.4K
Earning Date
10-29-2026
11-02-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 116.43
N/A
EPS
★ 1.30
N/A
Revenue
★ $1,301,360,000.00
N/A
Revenue This Year
$12.99
N/A
Revenue Next Year
$16.38
N/A
P/E Ratio
$11.25
★ N/A
Revenue Growth
★ 26.07
N/A
52 Week Low
$10.40
$15.79
52 Week High
$26.80
$28.38

Technical Indicators

Market Signals
Indicator
PGY
SPTX
Relative Strength Index (RSI) 27.93 38.96
Support Level $12.46 $15.79
Resistance Level $16.42 $22.57
Average True Range (ATR) 1.01 1.38
MACD -0.41 -0.33
Stochastic Oscillator 1.67 13.95

Price Performance

Historical Comparison
PGY
SPTX

About PGY Pagaya Technologies Ltd.

Pagaya Technologies Ltd is a product-focused technology company. It uses machine learning, a vast data network, and an AI-driven approach to offer comprehensive consumer credit and residential real estate products for its partners, their customers, and investors. Its suite of products includes Decline Monetization, Dual Look, First Look, Affiliate Optimizer Engine, Direct Marketing Engine, and FastPass, providing lenders with an AI-powered credit and acquisition ecosystem that helps them approve more borrowers, capture more demand, and grow without adding risk. Geographically, the company generates maximum revenue from its business in the United States.

About SPTX Seaport Therapeutics Inc. Common Stock

Seaport Therapeutics Inc is a clinical-stage therapeutics company. The company focuses on invention and development of new medicines for patients with depression, anxiety, and other debilitating neuropsychiatric disorders. The company identified clinically validated mechanisms with established efficacy and safety profiles, historically limited by high first-pass metabolism, low bioavailability, and side effects. The company's pipeline products are based on Glyph, company's lymphatic-targeting prodrug technology is designed to bypass first-pass metabolism and thereby enhance a drug's oral bioavailability and reduce side effects.

Share on Social Networks: